PharmAust Progresses to Elevated Doses of MPL in MND Patients Category: News and Announcements 2023By PharmAustJanuary 20, 2023Related postsNotice of General MeetingMay 26, 2023Motor Neurone Disease Clinical Trial UpdateMay 22, 2023Progress update on Phase 1/2 MND interim analysisMay 16, 2023Independent tests show MPL retains long-term shelf-lifeMay 10, 2023MPL has anti-cancer effects across multiple cancer typesMay 9, 2023PharmAust Raises $2.5m via PlacementMay 3, 2023